Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Fish and Richardson
Daiichi Sankyo
Fuji
Johnson and Johnson
Julphar
UBS
Chinese Patent Office

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006441

« Back to Dashboard

NDA 006441 describes CAMOQUIN HYDROCHLORIDE, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the CAMOQUIN HYDROCHLORIDE profile page.

The generic ingredient in CAMOQUIN HYDROCHLORIDE is amodiaquine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the amodiaquine hydrochloride profile page.
Summary for 006441
Tradename:CAMOQUIN HYDROCHLORIDE
Applicant:Parke Davis
Ingredient:amodiaquine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 006441

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Teva
Fuji
AstraZeneca
McKesson
Moodys
Express Scripts
Medtronic
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.